Sandi Bihary-Waltz is a senior level executive and subject matter expert with extensive knowledge of the rare disease and hematology/oncology landscape. She has more than 30 years of experience coaching pharma, biotech, and CROs in effective global regulatory strategy development and implementation. She has also worked with BARDA as a subject matter expert for regulatory affairs and quality affairs.
She is a candidate for her Doctorate in Business Administration from Wilmington University (2023) and has a Master of Science in Nursing from Widener University. She earned her Bachelor of Science in Nursing from Carlow University. In 2018, she was the recipient of the Carlow Laureate award, in recognition of outstanding professional achievement and academics as well as acts of community service. In 2019, Sandi was recognized as one of the Outstanding Women in Business in Delaware, for her contribution to the pharmaceutical industry and community involvement.